Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
29.33
-0.10 (-0.34%)
Feb 10, 2026, 10:34 AM EST
Chugai Pharmaceutical Revenue
In the year 2025, Chugai Pharmaceutical had annual revenue of 1.26T JPY with 7.46% growth. Chugai Pharmaceutical had revenue of 343.50B in the quarter ending December 31, 2025, with 13.71% growth.
Revenue
1.26T JPY
Revenue Growth
+7.46%
P/S Ratio
12.00
Revenue / Employee
159.80M JPY
Employees
7,872
Market Cap
96.28B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.26T | 87.33B | 7.46% |
| Dec 31, 2024 | 1.17T | 59.24B | 5.33% |
| Dec 31, 2023 | 1.11T | -148.58B | -11.79% |
| Dec 31, 2022 | 1.26T | 260.19B | 26.02% |
| Dec 31, 2021 | 999.76B | 212.81B | 27.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |
| Tian'an Technology Group | 2.12M |
Chugai Pharmaceutical News
- 4 days ago - Japanese drugmakers slump after Trump unveils discount drug website - Reuters
- 12 days ago - Chugai Pharmaceutical Co., Ltd. (CHGCY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Chugai Pharmaceutical reports FY results - Seeking Alpha
- 12 days ago - Chugai Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 12 days ago - Chugai Pharma FY25 Results Climb, Sees Growth In FY26 Core Profit, Revenues - Nasdaq
- 26 days ago - Chugai Pharmaceutical Co., Ltd. (CHGCY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 2 months ago - Chugai Pharmaceutical Teams With Biomy For Development Of AI-based Cancer Pathology Program - Nasdaq
- 3 months ago - Chugai Pharmaceutical 9-month Net Income Rises - Nasdaq